Growth Metrics

Enanta Pharmaceuticals (ENTA) Profit After Tax Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 65.80%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 42.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 42.19%
Dec 31, 2025 46.44%
Sep 30, 2025 35.12%
Jun 30, 2025 19.43%
Mar 31, 2025 27.32%
Dec 31, 2024 33.28%
Sep 30, 2024 -2.55%
Jun 30, 2024 42.00%
Mar 31, 2024 17.26%
Dec 31, 2023 -15.25%
Sep 30, 2023 -6.68%
Jun 30, 2023 -23.23%
Mar 31, 2023 -12.10%
Dec 31, 2022 3.75%
Sep 30, 2022 -7.11%
Jun 30, 2022 -31.95%
Mar 31, 2022 -52.38%
Dec 31, 2021 -261.61%
Sep 30, 2021 16.16%
Jun 30, 2021 -68.41%
Mar 31, 2021 -267.11%
Dec 31, 2020 -161.95%
Sep 30, 2020 -419.24%
Jun 30, 2020 -302.74%
Mar 31, 2020 -244.87%
Dec 31, 2019 -48.32%
Sep 30, 2019 -66.48%
Jun 30, 2019 -65.32%
Mar 31, 2019 -66.99%
Dec 31, 2018 122.45%
Sep 30, 2018 -24.89%
Jun 30, 2018 340.78%
Mar 31, 2018 332.84%
Dec 31, 2017 334.80%
Sep 30, 2017 2,125.97%
Jun 30, 2017 -683.09%
Mar 31, 2017 -227.78%
Dec 31, 2016 -119.02%
Sep 30, 2016 -131.00%
Jun 30, 2016 -144.50%
Mar 31, 2016 -105.72%
Dec 31, 2015 -37.66%
Sep 30, 2015 215.27%
Jun 30, 2015 -95.17%
Mar 31, 2015 652.62%
Dec 31, 2014 882.29%
Sep 30, 2014 -13.48%
Jun 30, 2014 1,309.59%
Mar 31, 2014 -38.78%
Dec 31, 2013 -124.46%
Sep 30, 2013 -9.65%
Jun 30, 2013 -18.19%
Mar 31, 2013 -111.68%